NYSEAMERICAN:INFU InfuSystem (INFU) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free INFU Stock Alerts $8.63 -0.17 (-1.93%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$8.55▼$8.8250-Day Range N/A52-Week Range$7.45▼$11.44Volume44,560 shsAverage Volume53,937 shsMarket Capitalization$182.78 millionP/E Ratio287.76Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainability Get InfuSystem alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About InfuSystem Stock (NYSEAMERICAN:INFU)InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Read More INFU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INFU Stock News HeadlinesMarch 26, 2024 | investorplace.comDouble Down: 7 Beaten-Down Growth Stocks to Buy Hand Over FistMarch 20, 2024 | money.usnews.comInfuSystem Holdings IncMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: InfuSystem Holdings, Inc. (INFU), Aquestive Therapeutics (AQST)March 15, 2024 | finance.yahoo.comInfuSystem Holdings, Inc. (AMEX:INFU) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comQ4 2023 InfuSystem Holdings Inc Earnings CallMarch 14, 2024 | msn.comInfuSystem GAAP EPS of $0.00 in-line, revenue of $31.77M beats by $1.77MMarch 14, 2024 | finance.yahoo.comInfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023March 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 14, 2024 | finance.yahoo.comInfuSystems Holdings Inc (INFU) Reports Solid Growth in 2023 with Record Net Revenues and ...March 8, 2024 | businesswire.comInfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024February 29, 2024 | seekingalpha.comInfuSystem Holdings: 2024 Will Be A Year Of MonetizationFebruary 1, 2024 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: EDAP TMS (EDAP), DermTech (DMTK)January 10, 2024 | markets.businessinsider.comAnalysts’ Top Consumer Cyclical Picks: Carbon Revolution (CREV), Kura Sushi USA (KRUS)January 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Dynavax (DVAX)January 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Streamline Health Solutions (STRM), MiMedx Group (MDXG) and Integra Lifesciences (IART)November 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), BioLife Solutions (BLFS) and Xeris Pharmaceuticals (XERS)November 7, 2023 | msn.comInfuSystem GAAP EPS of $0.03, revenue of $31.9MNovember 6, 2023 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: ModivCare (MODV), Clearside Biomedical (CLSD)November 6, 2023 | msn.comInfuSystem Q3 2023 Earnings PreviewNovember 3, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), BioMarin Pharmaceutical (BMRN) and Atricure (ATRC)October 31, 2023 | finance.yahoo.comInfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023October 27, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: CVRx (CVRX) and Merit Medical Systems (MMSI)October 24, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Elevance Health (ELV)October 11, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Pulmonx (LUNG), Ligand Pharma (LGND)October 10, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Technology Stocks: E2open Parent Holdings (ETWO), Stratasys (SSYS) and PagerDuty (PD)October 9, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and CareDx (CDNA)See More Headlines Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSEAMERICAN:INFU Previous SymbolNYSE:INFU CUSIPN/A CIK1337013 Webir.infusystem.com Phone(124) 291-1210Fax800-455-4338Employees420Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E Ratio287.76 Forward P/E RatioN/A P/E GrowthN/ANet Income$870,000.00 Net Margins0.69% Pretax Margin1.36% Return on Equity1.75% Return on Assets0.85% Debt Debt-to-Equity Ratio0.63 Current Ratio2.08 Quick Ratio1.66 Sales & Book Value Annual Sales$125.79 million Price / Sales1.45 Cash Flow$0.64 per share Price / Cash Flow13.51 Book Value$2.32 per share Price / Book3.72Miscellaneous Outstanding Shares21,180,000Free Float17,265,000Market Cap$182.78 million OptionableNot Optionable Beta1.26 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Richard A. DiIorio (Age 49)CEO & Director Comp: $806.26kMs. Carrie A. Lachance B.S.N. (Age 47)M.B.A., R.N., President, COO & Director Comp: $473.54kMr. Barry G. Steele (Age 53)Executive VP & CFO Comp: $303.33kMr. Addam Chupa (Age 45)Executive VP & Chief Information Officer Jerod FunkeExecutive VP & Chief HR OfficerJeanie LatzCorporate SecretaryMore ExecutivesKey CompetitorsQuipt Home MedicalNASDAQ:QIPTClearPoint NeuroNASDAQ:CLPTOrchestra BioMedNASDAQ:OBIOProfound MedicalNASDAQ:PROFAlpha Tau MedicalNASDAQ:DRTSView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 23,976 shares on 3/11/2024Ownership: 5.030%Greenwood Capital Associates LLCSold 3,018 shares on 3/5/2024Ownership: 0.449%Meros Investment Management LPBought 3,709 shares on 2/15/2024Ownership: 4.174%Nuveen Asset Management LLCBought 9,354 shares on 2/15/2024Ownership: 0.349%Citadel Advisors LLCBought 1,800 shares on 2/15/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions INFU Stock Analysis - Frequently Asked Questions Are investors shorting InfuSystem? InfuSystem saw a increase in short interest in the month of February. As of February 29th, there was short interest totaling 270,600 shares, an increase of 14.6% from the February 14th total of 236,100 shares. Based on an average daily trading volume, of 41,500 shares, the short-interest ratio is currently 6.5 days. Currently, 1.5% of the shares of the stock are short sold. View InfuSystem's Short Interest. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) announced its quarterly earnings data on Monday, November, 15th. The medical instruments supplier reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of $0.03 by $0.05. The medical instruments supplier earned $26.57 million during the quarter, compared to analysts' expectations of $28 million. InfuSystem had a net margin of 0.69% and a trailing twelve-month return on equity of 1.75%. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS). Who are InfuSystem's major shareholders? InfuSystem's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (5.03%), Vanguard Group Inc. (5.03%), Meros Investment Management LP (4.17%), Wasatch Advisors LP (4.00%), Ranger Investment Management L.P. (3.26%) and First Eagle Investment Management LLC (2.54%). Insiders that own company stock include Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Kevin Whitman, Paul Andrew Gendron, R Rimmy Malhotra, Richard Dilorio and Thomas Mark Ruiz. View institutional ownership trends. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:INFU) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & CompanyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.